Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/20/2012CA2222000C Abundant extracellular products and methods for their production and use
03/17/2012CA2752396A1 Pertussis antibodies and uses thereof
03/15/2012WO2012034079A2 Macrolide dosage forms
03/15/2012WO2012034077A2 Compositions and methods related to attenuated staphylococcal strains
03/15/2012WO2012034067A1 Methods and compositions involving protective staphylococcal antigens
03/15/2012WO2012034039A2 Anti-il-1 beta antibodies and methods of use
03/15/2012WO2012034025A2 Human cytomegalovirus vaccine
03/15/2012WO2012033987A2 Anti-human folate receptor beta antibodies and methods of use
03/15/2012WO2012033911A2 Polyionic papilloma virus-like particle (vlp) vaccines
03/15/2012WO2012033814A2 Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
03/15/2012WO2012033518A1 Methods and compositions for treating metabolic disorders
03/15/2012WO2012033328A2 Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
03/15/2012WO2012033236A1 Mdck cell line adapted to serum-free culture and suspension culture, and method for preparing viruses for vaccine using cells thereof
03/15/2012WO2012033142A1 Hepatitis c virus liposome vaccine
03/15/2012WO2012032764A1 Ttll4 peptides and vaccines containing the same
03/15/2012WO2012032763A1 Vangl1 peptides and vaccines including the same
03/15/2012WO2012032526A2 Use of anti third party central memory t cells for anti-leukemia/lymphoma treatment
03/15/2012WO2012032498A2 Developments in meningococcal outer membrane vesicles
03/15/2012WO2012032489A1 Non-lipidated variants of neisseria meningitidis orf2086 antigens
03/15/2012WO2012032433A1 4-1bb binding molecules
03/15/2012WO2012032358A1 Immunogenic composition comprising neisseria menigitidis macrophage infectivity potentiator protein
03/15/2012WO2012032348A1 Foot and mouth disease virus with increased stability and its use as vaccine
03/15/2012WO2012032182A1 Oral veterinary preparations
03/15/2012WO2012032169A1 Vaccine against n. meningitidis
03/15/2012WO2012032080A1 Stabilised human fc
03/15/2012WO2012031760A1 Parvovirus mutated structural proteins comprising cross - protective b - cell epitopes of a hpv l2 protein as well as products and methods relating thereto
03/15/2012WO2012031752A2 Tuberculosis mutants
03/15/2012WO2012031530A1 Use of multi-target recombinant gene and protein thereof in the prevention or treatment of helicobacter pylori infection
03/15/2012WO2012031374A1 Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
03/15/2012WO2012031333A1 Companion animal treatments
03/15/2012WO2012006368A3 Compositions and methods for treating influenza
03/15/2012WO2011162904A3 Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use priority statement
03/15/2012WO2011160845A3 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment
03/15/2012WO2011160086A3 Use of b lymphocyte stimulator protein antagonists to treat asthma and other allergic and inflammatory conditions of the respiratory system
03/15/2012WO2011153477A3 Uses and compositions for treatment of hidradenitis suppurativa (hs)
03/15/2012WO2011147982A3 Monoclonal antibodies against her2 epitope
03/15/2012WO2011146828A3 Cancer treatment
03/15/2012WO2011140337A3 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
03/15/2012WO2011130611A3 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
03/15/2012WO2011119716A3 Flavivirus host range mutations and uses thereof
03/15/2012WO2011098569A9 Process for producing an allergen extract
03/15/2012WO2011089062A3 Pharmaceutical formulation for proteins
03/15/2012WO2011085071A3 Attenuated francisella mutants and methods of use
03/15/2012WO2011080209A3 Antibody formulation
03/15/2012WO2011069037A3 Stabilization and storage of biological pharmaceutical compositions
03/15/2012WO2010120365A3 Protein-carrier conjugates
03/15/2012WO2006024954A9 Domains and epitopes of meningococcal protein nmb1870
03/15/2012WO2003041560A3 Compounds and methods for treatment and diagnosis of chlamydial infection
03/15/2012US20120065573 Methods of Treating Vascular Lesions
03/15/2012US20120065385 Dendritic cell co-stimulatory molecules
03/15/2012US20120065374 Dendritic cell co-stimulatory molecules
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065238 Allantoin-containing skin cream
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
03/15/2012US20120065141 Stabilized biodegradable neurotoxin implants
03/15/2012US20120065130 Methods for treating congestive heart failure
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064569 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064169 Multiple antigen delivery system using hepatitis e virus-like particle
03/15/2012US20120064163 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
03/15/2012US20120064151 Enhanced immune response in avian species
03/15/2012US20120064144 Method of treating eczema
03/15/2012US20120064124 Macrolide dosage forms
03/15/2012US20120064120 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064119 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064117 Tetravalent influenza vaccine and use thereof
03/15/2012US20120064116 Influenza nucleic acid molecules and vaccines made therefrom
03/15/2012US20120064115 Recombinant virus-like particles encoded by multi-gene vector
03/15/2012US20120064112 Recombinant newcastle disease viruses useful as vaccines or vaccine vectors
03/15/2012US20120064111 Attenuated vaccines for non-segmented negative sense rna viruses
03/15/2012US20120064110 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
03/15/2012US20120064109 Immunogenic composition and uses thereof
03/15/2012US20120064108 Glycoconjugate vaccines
03/15/2012US20120064106 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa
03/15/2012US20120064105 Engineered Type IV Pilin of Clostridium difficile
03/15/2012US20120064104 Combinations including pneumococcal serotype 14 saccharide
03/15/2012US20120064103 Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
03/15/2012US20120064102 Peptide inducing xage-1b-specific immune reaction and utilization of same
03/15/2012US20120064101 Compounds and Methods Useful for Detection and Treatment of Cancer
03/15/2012US20120064099 Compounds that inhibit nfkb and bace1 activity
03/15/2012US20120064097 Enhanced Binding of Pro-Inflammatory Cytokines by Polysaccharide-Antibody Conjugates
03/15/2012US20120064096 BTLA Antibodies and Uses Thereof
03/15/2012US20120064095 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
03/15/2012US20120064094 Serotonin 5-HT3 Receptor Antagonists for Use in the Treatment of Lesional Vestibular Disorders
03/15/2012US20120064093 Antibody
03/15/2012US20120064092 Novel Target for Regulating Multiple Sclerosis
03/15/2012US20120064091 Dysfunction of the mitochondrial respiratory chain, methods for diagnosis, treatment and follow-up
03/15/2012US20120064090 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug
03/15/2012US20120064089 Anti-cxcl16 and anti-cxcr6 antibodies for the prevention and treatment of cancer and cancer cell migration
03/15/2012US20120064088 Methods of treating aneurysm
03/15/2012US20120064087 Methods to diagnose a required regulation of trophoblast invasion
03/15/2012US20120064086 High concentration antibody and protein formulations
03/15/2012US20120064085 ANTI-INFLUENZA M2e ANTIBODY
03/15/2012US20120064084 Signal transduction protein tab2
03/15/2012US20120064083 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064082 Aminoacyl trna synthetases for modulating hematopoiesis
03/15/2012US20120064081 Anti-kir3d antibodies
03/15/2012US20120064080 Human LY6-Big Molecules and Methods of Use
03/15/2012US20120064079 Compositions and Methods for Preventing Erythropoietin-Associated Hypertension
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 1823